Font Size: a A A
Keyword [Immune checkpoint inhibitor]
Result: 21 - 40 | Page: 2 of 5
21. Association Between Blood-based Tumor Mutation Burden And Efficacy Of Immune Checkpoint Inhibitors:A Meta-analysis
22. Analysis Of The Efficacy And Safety Of Immune Checkpoint Inhibitors In The Treatment Of Advanced Non-small Cell Lung Cancer
23. Immunohistochemical Double Staining Technique To Screen Patients With Non-small Cell Lung Cancer Suitable For PD-L1 Inhibitor Therapy
24. Studies On A PH-Responsive Pickering Nanoemulsion For Specified Spatial Delivery Of Immune Checkpoint Inhibitor And DOX
25. PDI-1 As An Immune-checkpoint Inhibitor For NSCLC And Melanoma
26. An Immune-related Gene Prognostic Index For Lung Adenocarcinoma
27. A Meta-analysis Of The Efficacy And Safety Of PD-1/PD-L1 Inhibitors In The Treatment Of Advanced Gastric Cancer
28. Research Progress Of PD-1/PD-L1 Inhibitors In Combined Therapy In Advanced Colorectal Cancer
29. Systematic Review Of The Efficacy And Safety Of Immunotherapy Combined With Chemotherapy In The First-line Treatment Of Advanced Esophageal Squamous Cell Carcinoma
30. Apatinib Combined With ICIs As A Preliminary Study On The Clinical Efficacy And Safety Of Third-line Treatment For Metastatic Gastric Cancer
31. Study On The Therapeutic Effect Of Immune Checkpoint Inhibitors On Breast Cancer
32. Berberine Diminishes Cancer Cell PD-L1 Expression And Promotes Anti-tumor Immunity Via Inhibiting The Deubiquitination Activity Of CSN5
33. Study Of The Effect Of PD-1 And TIGIT Molecules On TB-specific IFN-γ Secretion
34. Exploration Of The Optimal Combined Timing Of Chemotherapy And Immune Checkpoint Inhibitors
35. Determinants Of Immunotherapy Responses In Microsatellite-stable Gastric Cancers
36. Preliminary Analysis Of The Clinical And Immune Microenvironment Of Immune Checkpoint Inhibitors Pneumonitis
37. Molecular Mechanism Of Osimertinib Resistance Induced By EGFR L792F Mutation And PTPRD As A Biomarker For Immunotherapy In NSCLC
38. Bioinformatic Based Study On Efficacy Prediction And Validation Of Immune And Targeted Therapy In Gastric Cancer With CIN Subtype
39. Analysis Of Radiation Therapy Enhancing The Response Of Immune Checkpoint Inhibitor Therapy In A Melanoma Murine Model
40. Exploration Of Predictive Biomarkers And Treatment Strategies For Immunotherapy In Advanced Non-small Cell Lung Cancer
  <<First  <Prev  Next>  Last>>  Jump to